Fingerprint Dive into the research topics of 'Mipsagargin, a novel thapsigargin-based PSMA-Activated prodrug: Results of a first-in-man phase i clinical trial in patients with refractory, advanced or metastatic solid tumours'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically